MAPT and Alzheimer disease: Since the APPPS1-21 mouse model does not have the fully developed tau pathology found in AD, tau seeding and spreading were induced by injecting sarkosyl-insoluble tau aggregates isolated from the postmortem brains of patients with AD (15–18) into the brains of APPPS1:E3 or APPPS1:E4 mice.